UNITAID has raised $2B through airline tax since 2006, could be model for G20 development funding, UNITAID chair says

UNITAID, an international drug financing program established to help fight HIV/AIDS, tuberculosis and malaria in developing countries, has raised about $2 billion since 2006 through taxes on airline tickets in 15 countries, Philippe Douste-Blazy, chair of the UNITAID executive board, told reporters in Washington on Wednesday, Agence France-Presse reports. According to Douste-Blazy, UNITAID's experience could provide a model for G20 development funding efforts.

The former French foreign minister described UNITAID's funding mechanism as "painless" and "a way to find new sources of finance for development."

"With the financial crisis we are going to see a decline of ODA (official development aid)," Douste-Blazy said. The G20 November meeting "is the opportunity to have 2011 as the year of innovative financing," he said. "According to his calculations, a simple tax of 0.05 percent on foreign exchange transactions between banks could yield as much as $120 billion per year. A variable tobacco tax ranging from one to five cents a pack could raise $8 billion, he said," AFP reports.

Douste-Blazy also told reporters that he hopes to persuade China to join UNITAID when he visits the country in June (4/20).


    http://www.kaiserhealthnews.orgThis article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

    Comments

    The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
    Post a new comment
    Post

    While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

    Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

    Please do not ask questions that use sensitive or confidential information.

    Read the full Terms & Conditions.

    You might also like...
    Study finds artemisinin resistance in African children with severe malaria